Prognostic value of the cardiac fraction of fatty acid binding protein in patients with non-ST elevation acute coronary syndrome with concomitant type 2 diabetes

Aim. To study the association between a positive results of Heart-type fatty acid binding protein (h-FABP) test with the development of adverse outcomes during the year of observation in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) depending on the type 2 diabetes mellitus (DM-2) presence.

Material and methods. The study included 153 patients with NSTEACS hospitalized in the department of emergency cardiology in the period from March 2014 to January 2017. In addition to the standard examination, all patients underwent a qualitative analysis on the h-FABP in venous blood.

 Results. Kaplan–Meier estimator demonstrated a significant probability of a combined end point in patients with positive h-FABP, both with and without DM-2. H-FABP also acts as a marker for the development of adverse outcomes during the year after NSTE-ACS. Patients with adverse outcomes and type 2 diabetes mellitus had the highest frequency (100%) of positive test reactions.

Conclusion. H-FABP positive test when admitted to hospital may be considered as a predictor of adverse long-term outcomes in patients with NSTE-ACS. That statistics is most significant for patients with DM-2.

1. Official website of the Federal state statistics service. (In Russ.) http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/healthcare/2016 ( 07.07.2018).

2. Barbarash OL, Kashtalap VV. Management of patients with non-ST segment elevation acute coronary syndrome. Are all problems solved? Russian Heart Journal. 2016;15(5):320-6. (In Russ.) doi:10.18087/rhj.2016.5.2249.

3. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (8th edition). Diabetes mellitus. 2017;20(1S):1-112. (In Russ.) doi:10.14341/DM20171S8.

4. Dedov II, Shestakova MV, Aleksandrov AA, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (7th edition). Diabetes mellitus. 2015;18(1S):1-112. (In Russ.) doi:10.14341/DM20151S1-112.

5. Berns SA, Shmidt EA, Nagirniak ОA, et al. Role of cardiac-ankle vascular index in prediction of long term adverse outcomes in patients with non ST segment elevation acute coronary syndrome. Cardiovascular Therapy and Prevention. 2018;17(1):25-31. (In Russ.) doi:10.15829/1728-8800-2018-1-25-31.

6. Backus B, Six A, Kelder J, et al. Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department. Current Cardiology Reviews. 2011;7(1):2-8. doi:10.2174/157340311795677662.

7. Hamm CW, Bassand J-P, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011;32:2999-3054. doi:10.1093/eurheartj/ehr236.

8. Kashtanova EV, Voevoda MI, Kuimov AD, et al. Heart — type fatty acid binding protein in acute coronary syndrome. Russian Journal of Cardiology. 2012;(1):31-4. (In Russ.) doi:10.15829/1560-4071-2012-1-31-4.

9. Golikov AP, Burns, SA, Stryuk RI, et al. Factors of prognosis in patients with acute coronary syndrome without ST-segment elevation in combination with diabetes of the 2nd type (results register). Therapeutic archive. 2017;89(3):65-71. (In Russ.) doi:10.17116/terarkh201789365-71.

10. Kakorin SV, Iskandaryan RA, Mkrtumyan AM. Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials. Diabetes Mellius. 2016;19(2):141-9. (In Russ.) doi:10.14341/DM200412-6.

11. Titov VN. Diagnostic value of the content of troponin and cardiomyocyte protein binding fatty acids in blood plasma in acute coronary syndrome. Clinical medicine. 2017; 95(3):207-15. (In Russ.) doi:10.18821/0869-2084-2016-61-10-672-680.

12. Kakorin VA, Gasanov МZ, Gordeev IG, et al. Qualitative test for the fatty acid binding cardiac protein in early diagnostics of myocardial infarction: subanalysis of russian multi — center ISPOLIN. Russian Journal of Cardiology. 2017;(11):62-7. (In Russ.) doi:10.15829/1560-4071-2017-11-62-7.